Fig. 3
From: Childhood resolution of early abnormal miRNA following neonatal encephalopathy
Changes in miR-20b expression between vehicle and LPS-treated samples. (a-c) Graphs show relative (ΔCT) expression of miR-20b in the vehicle and LPS-treated samples in control children (a, n = 10), NE neonates (b, n = 8) and NE children (c, n = 11). Wilcoxon signed-rank tests were done between three independent cohorts. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Children control (blue), Neonates NE (orange) and children NE (purple).
